Found 3 results

Author Title Type [ Year]

Filters: Author is Tartaglia, J  [Clear All Filters]

2009

S. Rerks-Ngarm, Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J., Francis, D., Stablein, D., Birx, D., Chunsuttiwat, S., and Khamboonruang, C., “Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand”, N Engl J Med, vol. 361, pp. 2209-2220, 2009.

2000

R. Bures, Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., R Habib, E., Klein, M., Lazzarin, A., Stablein, D. M., Deers, M., Corey, L., Greenberg, M. L., Schwartz, D. H., and Montefiore, D. C., “Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1”, AIDS Res HumRetroviruses, vol. 16, pp. 2019-35, 2000.

1999

T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., “A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers”, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.